Hovstadius, B., Petersson, G. (2012). Factors leading to excessive polypharmacy.. Clinics in Geriatric Medicine. 28. 159-72.
Hovstadius, B., Petersson, G. (2011). Adherence, therapeutic intensity, and the number of dispensed drugs. Pharmacoepidemiology and Drug Safety. 20. 1255-1261.
Wadenberg, M., Fjällström, A., Federley, M., Persson, P., Stenqvist, P. (2011). Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability: involvement of the cholinergic muscarinic receptor. International Journal of Neuropsychopharmacology. 14. 644-654.
Hellström, L., Bondesson, Å., Höglund, P., Eriksson, T. (2011). Impact of the Lund Integrated Medicines Management model on medication appropriateness. 39th ESCP European symposium on clinical pharmacy & 13th SFPC congress: clinical pharmacy at the front line of innovations. 21–23 October 2010, Lyon, France.
Wadenberg, M. (2010). Active Avoidance. Encyclopedia of Psychopharmacology : Part 1. Heidelberg, Springer Berlin/Heidelberg. 15-19.
Wadenberg, M. (2010). Conditioned avoidance response in the development of new antipsychotics.. Current pharmaceutical design. 16. 358-370.
Wadenberg, M., Fjällström, A., Karlsson-Federley, M., Persson, P., Stenqvist, P. (2010). Effects of adjunct galantamine to antipsychotics in animal models of antipsychotic activity and extrapyramidal side effect liability: Cholinergic muscarinic receptor mediation.
Ax, F., Ekedahl, A. (2010). Electronic transmitted prescriptions not picked up at pharmacies in Sweden. Research in Social and Administrative Pharmacy. 6. 70-77.
Frisk, P., Carlsten, A., Rydberg, T., Ekedahl, A. (2010). Patients' experiences with generic substitution-a Swedish pharmacy survey. .
Castensson, S., Ekedahl, A. (2010). Pharmaceutical Waste: The Patient Role. Green and Sustainable Pharmacy. Heidelberg Dordrecht London New York, Springer. 179-200.
